like
phylogroup
lyssavirus
circul
within
bat
reservoir
adapt
pseudotyp
pt
neutralis
assay
pna
multiplex
format
enabl
serosurveil
lago
bat
viru
lbv
mokola
viru
mokv
west
caucasian
bat
viru
wcbv
potenti
reservoir
african
strawcolour
fruit
bat
eidolon
helvum
highli
correl
titr
observ
singl
multiplex
pna
use
ptlbv
ptmokv
r
p
b
valid
use
bat
serosurveil
bat
serum
sampl
screen
neutralis
ptlbv
ptmokv
ptwcbv
mean
vnab
titr
ptlbv
ptmokv
ptwcbv
respect
high
seropreval
estim
suggest
infect
rate
lbv
e
helvum
remain
high
enough
persist
speci
support
hypothesi
lbv
endem
ghanaian
e
helvum
specul
lbv
may
coevolv
african
megachiroptera
substanti
evid
exist
suggest
lyssavirus
evolv
chiropteran
bat
host
infect
lyssaviru
famili
rhabdovirida
caus
rabi
encephalomyel
case
indistinguish
clinic
present
regardless
speci
infect
individu
lyssaviru
speci
mokola
viru
mokv
distribut
new
old
world
bat
fook
rabi
viru
rabv
routin
isol
new
world
bat
lyssaviru
speci
isol
old
world
bat
includ
lago
bat
viru
lbv
duvenhag
viru
duvv
european
bat
lyssaviru
type
eblv
eblv
australian
bat
viru
ablv
irkut
viru
irkv
khujand
viru
khuv
west
caucasian
bat
viru
wcbv
mokv
isol
terrestri
mammal
although
surveil
limit
nel
et
al
recent
put
new
speci
shimoni
bat
viru
shibv
isol
kenyan
bat
approxim
speci
bat
compris
extant
mammalian
speci
live
everi
contin
antarctica
teel
et
al
becom
clear
design
rabi
free
nation
uk
australia
endem
lyssavirus
circul
within
bat
popul
banyard
et
al
warrilow
nation
human
die
lyssaviru
infect
transmit
bat
fook
et
al
fraser
et
al
geograph
distribut
bat
togeth
appar
ubiquit
infect
bat
popul
lyssavirus
mean
except
antarctica
ocean
island
new
lyssavirus
may
spillov
reservoir
popul
new
potenti
reservoir
dog
deadend
host
human
anywher
globe
true
threat
human
anim
popul
pose
spillov
virus
unknown
due
lack
knowledg
epidemiolog
molecular
level
fook
report
human
infect
lyssavirus
rabv
rare
johnson
et
al
fatal
real
number
case
unknown
due
limit
surveil
misdiagnosi
mallewa
et
al
nel
rupprecht
lyssaviru
speci
belong
one
two
phylogroup
base
cross
neutralis
profil
pathogen
genet
related
badran
et
al
kuzmin
et
al
lbv
mokv
belong
phylogroup
other
compris
phylogroup
apart
shibv
wcbv
await
offici
classif
tent
place
phylogroup
put
phylogroup
respect
world
health
organis
estim
human
death
year
rabi
worldhealthorganis
primarili
due
rabv
circul
global
domest
dog
wild
carnivor
fox
skunk
racoon
potenti
epidem
virus
current
biolog
offer
protect
lbv
mokv
wcbv
possibl
shibv
hanlon
et
al
kuzmin
et
al
determin
infect
dynam
virus
understood
within
reservoir
host
absenc
known
mokv
reservoir
exampl
substanti
gap
understand
lyssaviru
ecolog
evolut
suggest
shrew
famili
soricida
reservoir
number
isol
shrew
current
limit
five
sabeta
et
al
three
isol
singl
studi
shope
et
al
four
recognis
lyssaviru
speci
rabv
mokv
duvv
lbv
shibv
isol
african
mammal
king
et
al
king
et
al
kuzmin
et
al
kuzmin
et
al
sabeta
et
al
sabeta
et
al
van
thiel
et
al
lbv
reportedli
contain
least
two
clade
diverg
enough
suggest
may
repres
differ
speci
delma
et
al
markott
et
al
rabv
mokv
never
isol
bat
africa
lbv
duvv
shibv
lbv
duvv
occasion
isol
mammal
kuzmin
et
al
sabeta
et
al
van
thiel
et
al
africa
therefor
possess
greatest
known
lyssaviru
divers
genet
serolog
given
divers
exist
africa
hypothesis
earli
evolut
diverg
lyssavirus
occur
african
bat
nel
rupprecht
recent
surveil
program
greater
access
serosurveil
techniqu
result
discoveri
high
seropreval
lbv
west
east
african
fruit
bat
dzikwi
et
al
hayman
et
al
kuzmin
et
al
wcbv
isol
bat
africa
isol
wcbv
miniopteru
bat
west
caucasu
botvinkin
et
al
howev
high
seropreval
antiwcbv
antibodi
detect
african
miniopteru
appropri
studi
undertaken
kuzmin
et
al
report
other
cleaveland
knobel
et
al
highlight
limit
understand
lyssaviru
epidemiolog
recent
streicker
et
al
suggest
phylogen
distanc
bat
speci
import
factor
crossspeci
transmiss
host
shift
rabi
virus
north
america
coupl
probabl
coevolut
lyssavirus
bat
possibl
speci
specif
shown
lyssavirus
isol
eurasia
wcbv
european
bat
lyssavirus
epidemiolog
studi
todat
could
caus
intrins
innat
restrict
factor
similar
report
retrovirus
neil
bieniasz
howev
given
lbv
isol
five
differ
speci
frugivor
insectivor
bat
behaviour
ecolog
cell
entri
restrict
could
also
import
factor
determin
lyssavirus
suscept
given
bat
extraordinarili
small
mani
common
speci
weigh
less
g
handl
anim
particular
bleed
live
anim
obtain
adequ
volum
sera
particularli
difficult
inde
sever
seropreval
studi
report
pool
sera
necessari
method
enabl
serolog
test
undertaken
studi
scotland
brook
et
al
current
studi
bat
lyssaviru
ecolog
evolut
africa
hamper
resourcelimit
laboratori
requir
larg
volum
sera
routin
viru
neutralis
antibodi
vnab
test
studi
adapt
lyssaviru
pseudotyp
neutralis
assay
pna
wright
et
al
wright
et
al
multiplex
format
allow
indepth
serosurveil
undertaken
spillov
phylogroup
two
lyssavirus
potenti
caus
fatal
zoonot
transmiss
event
deadend
host
human
emerg
terrestri
carnivor
due
limit
data
avail
unknown
whether
virus
endem
within
bat
popul
whether
speci
specif
order
address
undertook
investig
determin
previous
report
high
seropreval
antilbv
antibodi
ghanaian
fruit
bat
eidolon
helvum
e
helvum
due
recent
epidem
within
coloni
due
endem
infect
addit
test
hypothesi
lyssaviru
circul
speci
specif
undertook
seropreval
studi
lbv
mokv
phylogroup
wcbv
put
phylogroup
potenti
reservoir
e
helvum
use
novel
multiplex
pna
assay
detail
bat
sampl
provid
tabl
briefli
bat
caught
three
roost
coloni
site
urban
accra
kumasi
rural
tanoboas
ghana
fig
serum
sampl
collect
manual
restrain
anim
fig
classif
use
dichotom
key
previous
describ
hayman
et
al
reveal
e
helvum
singl
sampl
sexual
matur
male
hypsignathu
monstrosu
caught
tanoboas
eightyon
percent
e
helvum
sampl
studi
male
major
bat
sexual
matur
male
femal
undertook
definit
studi
compar
titr
achiev
lbv
pna
modifi
fluoresc
antibodi
viru
neutralis
assay
mfavn
bat
serum
sampl
analysi
vnab
titr
obtain
serum
sampl
use
pna
mfavn
reveal
correl
p
b
pearson
productmo
correl
fig
serum
sampl
neutralis
ptrabv
challeng
viru
standard
dilut
data
shown
sampl
score
classifi
vnab
posit
use
paramet
sensit
specif
pna
high
respect
nine
serum
sampl
classifi
neg
pna
posit
mfavn
posit
pna
neg
mfavn
fig
note
discord
result
assay
occur
low
vnab
titr
obtain
much
inform
possibl
sampl
multiplex
platform
incorpor
pna
made
possibl
measur
vnab
titr
two
differ
lyssavirus
well
use
equal
volum
sera
standard
pna
pilot
experi
undertaken
bat
serum
sampl
use
ptlbv
carri
renilla
luciferas
gene
ptmokv
encod
firefli
luciferas
gene
standard
dual
pna
undertaken
sampl
analysi
vnab
titr
obtain
assay
reveal
strong
correl
result
standard
dual
pna
p
b
pearson
productmo
correl
fig
strong
correl
also
observ
similar
experi
undertaken
time
use
renilla
luciferas
report
firefli
luciferas
report
sera
cover
rang
titr
dog
rabbit
previous
immunis
commerci
rabv
vaccin
isol
respect
p
b
pearson
productmo
correl
supplementari
fig
crossneutralis
lyssaviru
speci
lbv
mokv
anticip
greater
variat
low
vnab
titr
obtain
use
singl
dual
assay
due
satur
antibodi
avail
antigen
correl
ptlbv
ptmokv
vnab
titr
achiev
use
singl
dual
pna
sampl
vnab
titr
singl
pna
less
mean
lower
mean
significantli
strong
correl
maintain
r
p
b
p
b
respect
singl
dual
pna
data
supplementari
fig
sampl
vnab
titr
singl
pna
less
mean
stronger
correl
titr
greater
mean
r
p
b
p
respect
serum
sampl
screen
n
neutralis
ptlbv
n
neutralis
ptmokv
n
neutralis
ptwcbv
fig
accra
bat
sera
neutralis
ptlbv
ptmokv
ptwcbv
respect
kumasi
tanoboas
ptlbv
ptmokv
ptwcbv
neutralis
serum
sampl
respect
eleven
percent
serum
sampl
neutralis
ptlbv
ptmokv
sampl
neutralis
ptlbv
ptwcbv
ptmokv
ptwcbv
sampl
neutralis
pseudovirus
mean
vnab
titr
across
serum
sampl
test
ptlbv
ptmokv
ptwcbv
fig
statist
differ
vnab
percentag
neutralis
sera
titr
among
three
sampl
site
p
b
kruskalw
test
four
sampl
neutralis
ptmokv
ptlbv
ptwcbv
sampl
higher
vnab
titr
ptmokv
ptlbv
singl
h
monstrosu
seroposit
ptlbv
ptmokv
two
sampl
neutralis
ptwcbv
collect
accra
kumasi
geometr
mean
ic
endpoint
reciproc
dilut
titr
also
neutralis
ptlbv
respect
ptmokv
respect
neither
sampl
neutralis
activ
surveil
bat
undertaken
detect
vnab
andor
viral
rna
suggest
lyssaviru
speci
detect
circul
within
coloni
understand
viru
ecolog
bat
particularli
difficult
given
behaviour
ecolog
host
freul
et
al
vo
et
al
activ
infect
antibodi
rabv
variant
report
numer
bat
speci
north
south
america
belotto
et
al
bat
contin
old
world
mani
speci
lyssavirus
major
isol
bat
botvinkin
et
al
kuzmin
et
al
kuzmin
et
al
understand
virus
persist
differ
bat
popul
limit
particularli
outsid
america
ecolog
exampl
poorli
understood
appear
endem
design
rabi
free
nation
uk
banyard
et
al
banyard
et
al
africa
exist
greater
lyssaviru
divers
intrigu
evid
lbv
wcbv
shibv
might
circul
within
differ
bat
speci
roost
kuzmin
et
al
advantag
use
pseudotyp
virus
altern
handl
live
viru
utilis
mani
laboratori
two
decad
primarili
use
gene
deliveri
gene
therapi
vector
naldini
et
al
zufferey
et
al
recent
antigen
substitut
pna
evalu
antivir
drug
potenc
aljofan
et
al
parri
et
al
su
et
al
serum
vnab
titr
temperton
et
al
temperton
et
al
wright
et
al
vaccin
immunogen
szecsi
et
al
szecsi
et
al
yang
et
al
target
antigen
antibodi
bind
assay
also
pna
shown
aid
identif
potent
broader
crossneutralis
mab
possibl
use
neutralis
assay
corti
et
al
strong
correl
high
sensitivityspecif
lbv
pna
mfavn
vnab
titr
observ
studi
valid
pna
use
altern
exist
serolog
assay
similar
pna
use
wide
influenza
research
answer
import
epidemiolog
biolog
question
equal
accur
result
live
viru
assay
alberini
et
al
garcia
et
al
ad
flexibl
lyssaviru
pna
scaffold
includ
multiplex
platform
could
prove
valuabl
serosurveil
bat
incorpor
differ
luciferas
report
gene
viral
genom
differ
envelop
glycoprotein
viral
membran
separ
pseudotyp
prepar
possibl
detect
vnab
titr
two
virus
one
serum
dilut
hold
great
promis
bat
serolog
studi
scale
investig
usual
limit
volum
serum
collect
multiplex
pna
possibl
use
sera
obtain
vnab
titr
two
virus
twice
much
inform
standard
pna
postul
possibl
increas
capac
includ
pseudotyp
virus
encod
fluoresc
report
gene
gfp
rfp
signal
could
read
prior
cell
lysi
luciferas
measur
would
theoret
possibl
undertak
serosurveil
mani
highli
pathogen
virus
success
pseudotyp
exampl
filovirus
coronavirus
henipavirus
lyssavirus
low
contain
laboratori
use
one
serum
dilut
seri
tini
volum
serum
compar
requir
convent
assay
studi
observ
similar
seropreval
lbv
mokv
antibodi
e
helvum
report
african
serolog
studi
hayman
et
al
kuzmin
et
al
low
seropreval
wcbv
ghanaian
e
helvum
high
percentag
lbv
serum
posit
bat
approxim
year
hayman
et
al
first
detect
antilbv
antibodi
e
helvum
ghana
provid
support
hypothesi
lbv
endem
within
bat
popul
current
unknown
whether
seroposit
anim
ever
infecti
recov
neurolog
infect
whether
seroposit
evid
peripher
infect
prevent
reach
nervou
system
host
immun
respons
addit
difficulti
age
adult
wild
anim
problem
undertak
capturemarkrecaptur
studi
larg
popul
fli
wild
anim
current
limit
knowledg
regard
agespecif
seropreval
antibodi
titr
decay
rate
virushost
system
data
avail
conclus
regard
viru
infect
dynam
within
popul
limit
whether
lyssavirus
viral
infect
antibodi
detect
e
helvum
hayman
et
al
hayman
et
al
howev
result
suggest
risk
human
domest
anim
may
present
wherev
speci
occur
close
proxim
especi
given
food
sourc
across
much
africa
mickleburgh
et
al
small
proport
bat
serum
neutralis
one
lyssavirus
notabl
probabl
ptmokv
neutralis
observ
due
crossreact
lbv
vnab
report
previous
speci
kenya
nigeria
dzikwi
et
al
kuzmin
et
al
howev
detect
four
serum
sampl
neutralis
ptmokv
ptlbv
higher
vnab
titr
ptmokv
ptlbv
differ
possibl
explan
data
variabl
respons
individu
show
heterolog
antigen
might
explain
variat
shown
anim
kuzmin
et
al
smith
et
al
dynam
natur
biolog
test
might
also
affect
vnab
titr
testtotest
variat
possibl
also
genom
level
domain
contain
major
immunodomin
epitop
might
appear
differ
fold
antigen
site
might
adopt
similar
conform
altern
data
might
show
true
evid
previou
exposur
mokv
although
believ
variabl
immun
respons
heterolog
antigen
like
reason
result
particularli
given
degre
crossneutralis
previou
studi
dzikwi
et
al
kuzmin
et
al
also
interest
note
one
strong
one
weak
vnab
titr
record
ptwcbv
differ
serum
sampl
support
crossneutralis
caus
observ
provid
individu
vnab
titr
high
titr
ptlbv
ptmokv
perhap
demonstr
strong
immun
respons
lbv
lead
neutralis
lyssavirus
repres
seropreval
sampl
group
bat
far
record
wcbv
studi
suggest
even
though
serum
sampl
neutralis
result
constitut
convinc
evid
presenc
wcbv
circul
ghanaian
bat
therefor
analysi
result
previou
studi
suggest
possibl
speci
specif
certain
bat
lyssavirus
lbv
rna
antibodi
detect
differ
bat
speci
dzikwi
et
al
hayman
et
al
kuzmin
et
al
mokv
infect
never
report
bat
wcbv
isol
miniopteru
speci
botvinkin
et
al
kuzmin
et
al
evid
lbv
wcbv
infect
report
within
cave
coloni
differ
bat
speci
kuzmin
et
al
b
may
suggest
restrict
host
rang
certain
lyssavirus
possibl
due
cellular
behaviour
ecolog
restrict
may
evolv
coevolut
host
viru
howev
intens
far
reach
virolog
studi
mokv
wcbv
might
isol
bat
one
speci
respect
therefor
seropreval
studi
need
elucid
true
distribut
lbv
mokv
wcbv
propos
multiplex
pna
describ
substanti
improv
surveil
capabl
given
studi
also
provid
evid
endem
circul
lbv
within
bat
popul
urban
centr
studi
necessari
order
understand
viru
dynam
popul
level
speci
specif
cellular
level
result
studi
increas
understand
natur
histori
lyssavirus
provid
first
evid
lago
bat
viru
might
endem
urban
dwell
e
helvum
bat
popul
use
novel
multiplex
pna
also
detect
neutralis
mokv
wcbv
lbv
antibodi
posit
sera
observ
coupl
least
dozen
document
case
nonrabv
lyssaviru
spillov
event
human
fatal
rate
belikov
et
al
johnson
et
al
mani
case
probabl
unrecord
misdiagnos
rabv
infect
clear
extent
public
health
threat
pose
zoonot
transmiss
highli
pathogen
lyssavirus
bat
still
entir
understood
particular
understand
lyssaviru
dynam
whether
bat
lyssavirus
restrict
host
speci
rang
necessari
order
understand
potenti
risk
crossspeci
transmiss
viru
spill
therefor
studi
lead
greater
understand
lyssaviru
molecular
biolog
epidemiolog
requir
address
knowledg
gap
ultim
aid
design
novel
antivir
emerg
virus
lbv
nigeria
isol
boulger
porterfield
shope
et
al
use
mfavn
assay
produc
infecti
pseudotyp
particl
use
pna
glycoprotein
g
gene
genbank
access
number
nigerian
mokv
isol
kemp
et
al
shope
et
al
genbank
access
number
amplifi
use
specif
primer
supplementari
tabl
clone
pucbas
express
plasmid
wcbv
ggene
kuzmin
et
al
chemic
synthesis
genescript
usa
subclon
express
concurr
hiv
type
gagpol
plasmid
one
follow
report
plasmid
pcsgw
gfp
pcsflw
firefli
luciferas
pcsrlw
renilla
luciferas
detail
inform
regard
plasmid
pseudoviru
product
titrat
given
previous
wright
et
al
wright
et
al
apart
pcsrlw
compris
pcsgw
backbon
renilla
luciferas
gene
subclon
place
gfp
gene
alberini
et
al
demaison
et
al
gfp
pseudotyp
titr
compar
infecti
unit
ifu
ml
ptwcbv
ifuml
log
lower
ifuml
highli
transfect
deriv
cell
line
human
embroyon
kidney
cell
hek
atcc
use
pseudotyp
product
maintain
dulbecco
modifi
eagl
medium
dmem
supplement
glutamax
foetal
calf
serum
fc
co
babi
hamster
cell
atcc
use
pseudotyp
mfavn
neutralis
assay
cultur
dmem
fc
penicillinstreptomycin
co
march
serum
sampl
collect
three
larg
e
helvum
coloni
within
ghana
accra
urban
n
kumasi
urban
n
tanoboas
rural
n
fig
ethic
approv
captur
studi
bat
given
zoolog
societi
london
ethic
committe
bat
caught
use
mist
net
return
roost
site
blood
sampl
taken
propatagi
vein
bat
manual
restrain
fig
sera
prepar
centrifug
blood
rpm
min
heattreat
min
storag
immedi
six
serum
sampl
contain
insuffici
volum
test
mokv
vnab
separ
rabbit
antisera
rais
isol
duvenhag
viru
isol
recov
bat
zimbabw
johnson
et
al
use
posit
control
sera
pna
standard
singl
pseudotyp
neutralis
assay
conduct
previous
describ
wright
et
al
wright
et
al
allow
detect
vnab
two
pseudovirus
one
well
tissu
cultur
plate
use
serum
multiplex
dual
assay
develop
assay
undertaken
use
protocol
singl
assay
apart
two
lyssaviru
pseudotyp
tcid
ad
well
assay
plate
one
contain
firefli
luciferas
report
gene
renilla
luciferas
report
gene
follow
normal
h
incub
plate
assay
use
reagent
promega
uk
instead
reagent
promega
uk
detail
manufactur
instruct
reagent
differenti
firefli
renilla
luciferas
signal
vnab
titr
lyssaviru
pseudotyp
could
record
serum
sampl
concurr
neutralis
data
report
studi
undertaken
use
lbv
mokv
wcbv
pna
allow
comparison
vnab
titr
sampl
also
test
lbv
mfavn
undertaken
describ
previous
hayman
et
al
wide
use
favn
assay
titr
report
correspond
neutralis
pseudotyp
viru
input
report
ic
endpoint
reciproc
dilut
statist
analys
undertaken
use
graphpad
prism
graphpad
softwar
san
diego
ca
usa
note
method
score
sera
posit
neg
mfavn
pna
use
previou
studi
sera
crossneutralis
hayman
et
al
absenc
known
uninfect
e
helvum
coloni
sensit
specif
assay
known
howev
hayman
et
al
dilut
threefold
dilut
dilut
viru
neutralis
use
standard
favn
method
rabi
cliquet
et
al
therefor
deem
accept
cutoff
similarli
observ
neutralis
dilut
use
pna
serum
sampl
collect
current
studi
data
shown
therefor
consid
mean
neutralis
titr
next
dilut
seri
pna
mfavn
seroposit
supplementari
materi
relat
articl
found
onlin
